Building Flagship Pioneering With Avak Kahvejian, Ph.D.
Business Of Biotech
The Future of Biopharma Platforms
A lot of these companies especially in a tumultuous vc and capital markets environment all these companies like the idea of having a platform that they can maybe license for development and target identification and so on to other biopharma companies while funding their own pipeline. There's myriad permutations of the model what is it a flagship like are these platforms proprietary for the most part you know serving the flagship companies? Is there the intention perhaps that some of these platforms could be made for greater use to the the greater bio pharmaceutical industry than just being used by one company or another? We run into this case all the time at some point that company says well to demonstrate and we've matured this platform to a point where
